CA1257166A - Catheter assembly - Google Patents
Catheter assemblyInfo
- Publication number
- CA1257166A CA1257166A CA000520661A CA520661A CA1257166A CA 1257166 A CA1257166 A CA 1257166A CA 000520661 A CA000520661 A CA 000520661A CA 520661 A CA520661 A CA 520661A CA 1257166 A CA1257166 A CA 1257166A
- Authority
- CA
- Canada
- Prior art keywords
- cannula
- duct
- cross
- end portion
- hub
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/0009—Making of catheters or other medical or surgical tubes
- A61M25/0014—Connecting a tube to a hub
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/01—Introducing, guiding, advancing, emplacing or holding catheters
- A61M25/06—Body-piercing guide needles or the like
- A61M25/0606—"Over-the-needle" catheter assemblies, e.g. I.V. catheters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/0021—Catheters; Hollow probes characterised by the form of the tubing
- A61M25/0023—Catheters; Hollow probes characterised by the form of the tubing by the form of the lumen, e.g. cross-section, variable diameter
- A61M2025/0024—Expandable catheters or sheaths
Abstract
CATHETER ASSEMBLY
Abstract A catheter assembly comprises a cannula having proximal and distal end portions and a longitudinal duct having an initial inner cross-section. The duct increases in cross-section when at least a part of the distal end portion of the cannula is inserted into a body of a living subject and maintained in contact with the body, and/or when the duct is contacted by an aqueous liquid, fox a period of time sufficient for an enlarged duct cross-section to form. A hub has a passageway from a first to a second end thereof.
The passageway has a cross-sectional area throughout at least substantially equal to 125% of the initial inner cross-section of the duct. A proximal end portion of the cannula is attached to the first end of the hub with a passageway through the hub in flow communication with the duct in the proximal and portion of the cannula. The attaching is such that the cross-section of the duct adjacent the proximal end portion, following formation of the enlarged duct cross-section, is throughout at least substantially equal to the cross-sectional area of the passageway. Increased flow is provided through the hub whereby advantage can be taken of the expansion of the duct.
Abstract A catheter assembly comprises a cannula having proximal and distal end portions and a longitudinal duct having an initial inner cross-section. The duct increases in cross-section when at least a part of the distal end portion of the cannula is inserted into a body of a living subject and maintained in contact with the body, and/or when the duct is contacted by an aqueous liquid, fox a period of time sufficient for an enlarged duct cross-section to form. A hub has a passageway from a first to a second end thereof.
The passageway has a cross-sectional area throughout at least substantially equal to 125% of the initial inner cross-section of the duct. A proximal end portion of the cannula is attached to the first end of the hub with a passageway through the hub in flow communication with the duct in the proximal and portion of the cannula. The attaching is such that the cross-section of the duct adjacent the proximal end portion, following formation of the enlarged duct cross-section, is throughout at least substantially equal to the cross-sectional area of the passageway. Increased flow is provided through the hub whereby advantage can be taken of the expansion of the duct.
Description
~L2S73L66 Description CAT~.ETER ASSEMB1Y
Inventors: Jock M. Walker Uwayne E. ~ardy Technical Field The invention relates to a catheter assembly useful as a body implant for introduction of nutrients andJor medication to and/or extraction of fluids from an animal species. More particularly, the invention relates to a catheter assembly which utili~es a unique hub in combination with a cannula formulated of a material which expands: whereby increased fluid flow is attained.
Background A number of catheter assemblies are known which utilize a relatively ~ong flexible hollow plastic cannula for insertion into the vein ~f a patient for the infusion of intravenous fluids including nutrients and/or medication. ~enerallv, one end of the cannula is attached to the hub and a steel needle which is si~ed to fit within the duct of the cannula is inserted into the hub from the side opposite the attachment of the cannula ~2$~7~6~i sufficient:Ly so that the steel needle exits the cannula at its distal end. The needle is then inserted into the vein oE a patient after which it is removed from the cannula and the hub, leaving the cannula hehind with its distal end in the vein. An intras7enous feeding and/or medication tube is then attached to -the hub whereby flow can take place through the hub and the cannula and into the vein.
Catheter assemblies are also used Eor other purposes, or example, for endo~racheal tubes, and the like. Also, the cannula of such assemblies can be inserted by over the needle and through the needle techni~3ues and, in the case of endotracheal tubes or the like, without the use of a needle.
The cannulae of the prior art have generally been made of a rigid material which does not change the cross-sectional area of the duct of the cannula after insertion into a vein. More recently, as set Eorth in commonly assigned Canadian Patent application Serial No. 491,425 filed September 24, 1986 (and Pc~r/us 85/01808 filed September 20, 1985 and published ~qarch 27, 1986 under
Inventors: Jock M. Walker Uwayne E. ~ardy Technical Field The invention relates to a catheter assembly useful as a body implant for introduction of nutrients andJor medication to and/or extraction of fluids from an animal species. More particularly, the invention relates to a catheter assembly which utili~es a unique hub in combination with a cannula formulated of a material which expands: whereby increased fluid flow is attained.
Background A number of catheter assemblies are known which utilize a relatively ~ong flexible hollow plastic cannula for insertion into the vein ~f a patient for the infusion of intravenous fluids including nutrients and/or medication. ~enerallv, one end of the cannula is attached to the hub and a steel needle which is si~ed to fit within the duct of the cannula is inserted into the hub from the side opposite the attachment of the cannula ~2$~7~6~i sufficient:Ly so that the steel needle exits the cannula at its distal end. The needle is then inserted into the vein oE a patient after which it is removed from the cannula and the hub, leaving the cannula hehind with its distal end in the vein. An intras7enous feeding and/or medication tube is then attached to -the hub whereby flow can take place through the hub and the cannula and into the vein.
Catheter assemblies are also used Eor other purposes, or example, for endo~racheal tubes, and the like. Also, the cannula of such assemblies can be inserted by over the needle and through the needle techni~3ues and, in the case of endotracheal tubes or the like, without the use of a needle.
The cannulae of the prior art have generally been made of a rigid material which does not change the cross-sectional area of the duct of the cannula after insertion into a vein. More recently, as set Eorth in commonly assigned Canadian Patent application Serial No. 491,425 filed September 24, 1986 (and Pc~r/us 85/01808 filed September 20, 1985 and published ~qarch 27, 1986 under
2~o. W086/01813), materials have been developed which can be formulated into cannulae and which, while they are rigid enough to retain their shape during insertion, also, have the property of swelling to form an enlarged duct cross-section, due to water piclcup. P~lso, recent publications discuss cannulae which, on being raised to a temperature approaching body temperature undergo a shape chanye motivated by plastic memory, to form somewhat shorter, larger duct cross-section cannulae.
If such increasing duct cross-section cannulae as are discussed above are a~tached to the conventional hubs of the prior art the full effect 31 257~6~
of the increased duct cross-section, in ~low rate, cannot be realized because prior art hubs are such that flow will be limited either because of the size of the passageway through the hubs or because the hubs hold the cannulae in such a manner that instead of the cannulae proximal ends being held so that the duct cross section can increase, the cannulae are externally restrained whereby the duct cross-section is forced to decrease.
The present invention is directed to overcoming one or more of the problems as set forth above.
Disclosure Of The Invention One aspect of the present invention is a catheter assembly comprising a cannula having a proximal end portion, a distal end portion and a longitudinal duct therethrough, the cannula being of a material such that an inner cross-section of the duct increases to form an increased duct cross-section when at least a part of the distal end portion is inserte~ into a body of a living sub~ect and maintained in contact with the body, and/or when the duct is contacted by an a~ueous liquid, for a period of time sufficient for the enlarged duct cross-section to form. The catheter assemblv further includes a hub having a passageway therethrough from a first to a second end thereof, the passagewav having a cross-sectional area throughout at least substantiall~ equal to the enlarged duct cross-section. Attaching means are provided for attaching the proximal end portion of the cannula to the first end of the hub with the passageway through the hub in flow communication ,~, . ...
with the duct in the proximal end portion of the cannula, the attaching being in a manner such that the cross-sectional area of the duct adjacent the proximal end portion, following formation of the - 5 enlarged duct cross-section, is throughout at least substantially equal to the enlarged duct cross-section along the remainder of the cannula.
Another aspect of the present invention is a catheter assembly comprising a cannula having 10 proximal and distal end portions and a longitudinal duct therethrough, the cannula being of a material such that an inner cross-section of the duct increases to form an enlarged duct cross-section when at least a part of the distal end portion is 15 inserted into a body of a living subject and maintained there, and/or when the duct is contacted by an aqueous liquid, for a period of time sufficient for the enlarged cross-section to form.
The catheter assembly further comprises a hub having 20 a passageway therethrough from a first to a second end thereof, the passageway having a cross-sectional area throughout at least substantially equal to the enlarged duct cross-section, the first end of the hub and the proximal end portion of the cannula 25 being attached with the passageway and duct in flow communication, the attaching being in a manner such that the cross-sectional area of the duct adjacent the proximal end portion, following formation of the enlarged duct cross-section, is throughout at 30 least substantially equal to the enlarged duct cross-section along the remainder of the cannula.
Still another aspect of the present invention is a catheter assembly comprising a ~L~S~L6~i cannula having a proximal end portion, a distal end portion and a longitudinal duct therethrough, the duct haviny an initial inner cross-section which increases to form an increased duct cross-section when at least a part of the distal end portion of the cannula is inserted into a body of a living subject and maintained in contact with the body, and/or when the duct is contacted by an aqueous liquid, for a period of time sufficient for the enlarged duct cross-section to form. The catheter assembly further includes a hub having a paasageway therethrough from a first to a second end thereof, the passageway having a cross-sectional area throughout at least substantially equal to 125% of the initial inner cross-section of the duct.
Attaching means are provided for attaching the proximal end portion of the cannula to the first end of the hub with the passageway through the hub in flow communication with the duct in the proximal end portion of the cannula, the attaching being in a manner such that the cross-sectional area of the duct adjacent the proximal end portion, following formation of the enlarged duct cross-section, is throughout at least substantially equal to the cross-sectional area of the passageway.
Another aspect yet of the present invention is a catheter assembly comprising a cannula having proximal and distal end portions and a longitudinal duct therethrough, the duct having an initial inner cross-section which increases to form an enlarged duct cross-section when at least a part of the distal end portion of the cannula is inserted into a body of a living subject and maintained there, and/or when the duct is contacted by an ~s~
aqueous liquid, ~or a period of time sufficient for the enlarged cross-section to form. The catheter ~ssembly further comprises a hub having a passageway therethrough from a first to a second end thereof, the passageway having a cross~sectional area throughout at least substantially equal to 125% of the initial inner cross section of the duct, the first end of the hub and the pro~imal end portion of the cannula beinq attached with the passageway and duct in flow communication, the attaching being in a manner such that the cross-sectional area of the duct adjacent the proximal end portion, following ; formation of the enlarged duct cross-section, is throughout at least substantially equal to the cross-sectional area of the passageway.
Utilizing a catheter assembly in accordance with the present invention one can take full advantage of the enlarged duct cross-section in the cannula whereby one can utilize smaller steel needles and cannulae for insertion into the body to attain a throughput equal to that attained utilizing such relatively larger needles as are currently in use ox, alternatively, one can utili7e steel needles and cannulae of the size presentlv used an~ can ~hereby attain a much higher throu~hput.
Brief Description_Of The Drawings The invention will be better understood by reference to the figures of the drawings wherein like numbers denote like parts throughout and wherein:
Figure 1 is a perspective view of a catheter assembly in accordance with an embodiment of the present invention;
Figure 2a is a cross-sectional view of an embodiment of a hub and the preshaped proximal end portion of a cannula in accordance with an embodiment of the present invention in a non-expanded state;
~ Figure 2b is a ~iew similar to Figure 2a hut with the cannula in the expanded state;
Figure 3a is a view similar to Figure 2a but showing an alt~rnate embodiment of a catheter assembly in accordance with the present invention with the cannula in the non-expanded state;
Fiyure 3b is a view similar to Fi~ure 3a but with the cannula proximal end portion preshaped;
Figure 3c is a view similar to Figure 3a but with the cannula in the expanded s,tate;
Figure 4 illustrates, in a view similar to Figure 2a, another alternate embodiment in accordance with the present invention;
Figure 5a illustrates another embodiment yet of the present invention with the cannula in a non-expanded state;
Figure Sb illustrates a view similar to Figure 5a but with the cannula in its expanded state;
Fi~ure 5c illustrates an alternate embodiment of the present invention similar to ihat of Figure Sa but wherein the cannula has been preshaped at its proximal end portion;
: Figure 6a illustrates vet another embodiment of the present invention wherein the hub and cannula are o integral construction in the non-expanded state; and Figure 6b illustrates the embodiment of Figure 6a with the hub and cannula in the expanded state.
~est Mode For Carrying ~ut The Invention _ In the following description corre~ponding parts of the structures called out are clistinguished from one embodiment to another by preceeding the number of the part with the number of the Figure.
Thus, for example, part 216 in Figure 2 corresponds to part 316 in Figure 3, part 416 in Figure 4, part 516 in Figure 5, and part 616 in Figure 6. The fol Iowing discussion is directed to an over the ne~dle type of catheter assembly 10. However, while the discussion is limited in this manner such ~imitation is for convenience only. Thus, cannulae which are long tubes and short tubes, catheter assemblies which are inserted by other than an over the needle techniaue, and the like, also fall within the scope of the invention.
~he invention relates to a catheter assembly 10, one embodiment of which is seen~ in perspective in Figure 1. The catheter assembly 10 inc~udes a cannula 12 along with a hub 14 and attaching means 216, 316, 416 and 516 (seen in Figures 2-6). The cannula 1~ has a proximal end portion 18 and a distal end portion 20. A
longitudinal duct 222, 322, 422, 522 and 622 (Figures 2-6) is defined within the cannula 12 and extends therethrough from the proximal end portion 18 ~o the distal end portion 20. It is essential to the practice of the present invention that the cannula 12 be formulated of a material selected such that an inner cross-sectional area (at 224, 324, ~2~
_ 9 424, 524, 624) of the duct 222, 322, 422, 522, 62 increases to form an enlarged duct cross-sectional area (at 226, 326, 526, 626), generally enlarged from at least about 25~ Ito 125~ of its initial inner cross-section) to at least about 300%, preferably from about 40% to about 300%; for over the needle cannulae the enlargement is more preferably from about 35% to about 140% and most preferably from about 40% to about 100%; when at least a part of the distal end portion 20 of the cannula 12 is inserted into a body, generally into the blood stream, of a living subiect and maintained in contact with that body, and/or when the duct 22?, 322, 422, 522, 622 is contacted by, e.~., filled with, an aqueous liquid, for a time sufficient for the enlarged duct cross-section ~at 226, 326, 426, 526) to form.
In accordance with a preferred embodiment : of the present invention the cannula comprises a multiple phase polymeric composition comprising a first phase which comprises a substantially non-hydrophilic polymeric component and a second phase which comprises a hydrophilic polymeric component. The relative amounts of these components are selected, depending on the particular polymeric materials employed, to provide a composition havin~
the desired properties, as discussed more fully below.
Preferably the non-hydrophilic polymeric component forms a continuous phase. The hydrophilic polymeric component can form a co-continuous phase with, or a dispersed phase in, the non-hydrophilic po1ymer phase.
The non-hydrophilic polymeric component comprises a polymer which does not substanti~lly absorb or attract water. Preferably, the non-hydrophilic poIymer is capahle of absorbing in 5 an amount of no more than about 30~, more preferably no more than about 15%, and most preferably no more than about 10%, by weight, based on the weight of the non-hydrophilic polymer.
The non-hydrophilic polymer can be for example, a polyurethane such as an aliphatic polyurethane, a polyether polyurethane, a polvester polyurethane; an ethylene copolymer such as ethylene-vinyl acetate copolymer or ethylene-ethyl acrylate copolymer; a polyamide, in particular a polyamide of low crystallinity; an aliphatic polyester; or the like. A particularly preferred non-hydrophilic polymer is a polyurethane, especially an aliphatic polyurethane.
The hydrophilic po1ymer preferably is a polymer that absorbs at least about 50~ water, more preferably about 100~, for example, at least about 150~, by weight based on the weight of the hydrophilic polymer. The hydrophilic polymer preferably forms a hydrogel on absorption of water.
The hydrophilic polymer is preferably polyvinyl alcohol, poly(ethylene oxide), polypropylene oxide, poly(ethylene glvcol), polypropylene glycol, polytetramethylene oxide, polyvinyl pyrolidene, polyacrylamide, poly(hydroxy-ethyl acrylate), poly(hydroxyethyl methacrylate), or the like.
The multiple phase composition can be prepared by ~ixing the polymeric co~ponents or by forminq a block or ~raft copolymer containing the polymeric components. A mixture of the components can be prepared using, for example, a two-roll mill, an internal mixer, such as a Brabender or Banbur~
mixer, an extruder , e.g., twin-screw e~truder, or S the like. Block and graft copolymers can be prepared by appropriate methods depending on the particular nature of the components used. Typical preparatory methods can be found, for example, in "Block and Graft Copolymerization", R.J. Ceresa ~Zd) r 1973, Vol. 1 & 2, Wiley-Interscience, New York and "Block Copolymers", D.C. A~lport and W.H. Jane, 1973, Wiley, New York.
Generally, the ratio of non-hydrophilic polymeric component to hydrophilic polymeric component is 0.65:1 to 9:1. Preferably the ratio of the polymeric components is 1:1 to 9:1.
The polymeric components are selected to provide a multiple phase system. Generally, the polymeric components each have a mo]ecular weight of at least about 3,000 preferably at least about 5,000 and most preferably at least about 10,000.
As stated above, the relative amounts of non-hydrophilic and hydrophilic polymeric components are selected, depen~ing on the particular materials employed, to provide the desired properties. Due to the presence of the hydrophilic poly~eric component, the composition is capable of being hydrated by the absorption of water. As water is absorbed by the composition, it may soften with a so tening ratio of at least about 2:1, preferably at least 6:1, more preferably at least about 10:1, most preferably at least about 20:1, and in particular at about 40:1.
The term "softening ratio" is used herein to refer to the ratio of the 2.5% Secant modulus values of the composition, in the form of a tubular article, when substantially non-hydrated, to the 2.5~ Secant modulus of the composition when substantial~v completely hydrated. The term "substantially non-hydrated" refers to the state of the composition undex conventional ambient conditions, i.e., room temperature, 50-80% relative humi~ity and about atmospheric pressure. The term "substantially completely hydrated" refers to the state of the composition when it is in equilibrium with an excess of water at 37C and ambient pressure.
The composition may swell on absorption of water with a swelling ratio of at least about 1.3:1, preferably at least about 1.7:1 and most preferably at least about 2.0:1. The term "swelling ratio"
refers to the ratio of the volume of a ~iven sample of the composition when substantially completely hydrated to its volume when substantially non-hydrated.
Preferably the composition both softens and swells when placed in the body.
When substantially completely hydrated the composition has a tensile energy to break of at least about 700 Newton-centimeters per cubic centimeter (N-cm/cm3), preferably at least about 1,400 N-cm/cm and most preferably about 1,700 N-cm/cm . The term "tensile energy to break" (T~
is defined in ASTM-D882 as the area under the stress-strain curve or ... ~ . ... . . ~ ..
~2 ~
TEB = 5 Sd~
o where S is the stress at any strain, ~ ,; and ~
is the strain at rupture. The tensile energy to break provides an indication of the toughness of the hydrated composition and its ability to withstand the conditions it will be subjected to in use.
It will be readily appreciated that when a tubular product such as a cannula is withdrawn from the body it is extremely important that it does not tear or break leaving piece~ remaining inside the hody. Neither tensile strength nor elon~ation to break are good indicators of toughness. Brittle materials and notch sensitive materials can have tensile strengths~ Extremely weak materials can have high elon~ation but not the strength to survive extraction. TEB i5 a measure of the energy required to break and is a combination of these-two important criteria.
The ultimate elongation of the multiple phase composition should be at least about lO~, preferably at least about 25~ and most preferablv at least about 50~.
The composition when substantially completely hydrated has a 2.5~ Secant modulus of less than about 7,000 Newtons/s~uare centimeter ~N/cm2), preferably less than-about 3,500 N/cm2 and most preferably less than about 2,000 N/cm2. ~hen substantially completely hy~rated the 2.5~ Secant 3L;2~;7~
modulus can be as low as about 30 N/cm2 but preferably above about 60 N/cm2 and most preferahly above about 120 N/cm2.
Typically the 2.s% Secant modulus of the composition when substantially non-hydrated is at least about 20,000 N/cm2 when used as over the needle catheter in accordance with the present invention. Preferably the 2.5% ~ecant modulus of the composition is at least about ~8,000 N/cm2.
The composition may be crosslinked if desired. Crosslinking of the composition gives the polymeric composition strength above the melting or softening points of the polymeric components permitting steriliæation of a device utilizing the ~5 composition at above that temperature. This is particul~rly advantageous if the polymeric component of the continuous phase has a relatively low melting or softening point. Crosslinking of the composition may also be used to adjust the 2.5% Secant modulus of the composition to bring it to the desir~d value for the proposed use of the composition. When the composition comprises a physical mixture of the non hydrophilic and hydrophilic components, crosslinking of the mixture can controi the tendency of the hydrophilic component to leach out of the composition when it is in extended contact with water or body fluids. Crosslinking may also improve the toughness ~TEB) of the composition in the hydrated state.
Crosslinking of the composition can be effected by use of an appropriate crosslinking agent or by irradiation, preferably in the presence of a crosslinking promoter, such as triallyl isocyanurate, or the like. In a preferred embodiment the composition is crosslinked by high energy radiation from an electro~ accelerator. The amount of irradiation should be in the range of about 0.5 to about 30 ~egarads (Mrads) preferably about 0.5 to about 15 Mrads and most preferably about 0.5 to ~bout 10 Mrads.
Either or both components of the composition may contain additional ingrec7ients such as stabilizers, antioxidants, radiopacifiers, medicaments, fillers or the like. For certain applications it may be advantageous to incorporate a water soluble or water dispersible medicament which can leach from the composition of the cannula when it contacts body fluids. Such medicaments include anti-thrombogenic agents, antibiotics, anti-viral agents, anticoa~ulants, anti-inflammatory agents or the like.
The cannula should not swell or soften appreciably during the time it is being inserted in a vein or the like. It has been found that the time for the cannula to swell to 50% of its fully swollen volume should be at least ahout 15 seconds, prefera~ly at least about 60 seconds.
An alternative material which may be utilized as the cannula material is a thermoplastic material with shape-memory properties. Such polymeric compounds are described, for example, in the following articles: Softenable, Shape-Memory Thermoplastics For Biomedical ~7se, Robert S. Ward, MD7D, August 1985; and Thromboresistant, Radiopaquer Softenable Thermoplastic Catheter Compound With Shape-Memory Properties, R.S. Ward, K.A. White, J~S.
P.iffle, Second World Congress On Biomaterials, 10th Annual Meeting Of The Society For ~iomaterials, J ., I ~ ~ f .-~IL25~7~66 - lfi Washington, D.C., April 27-May 1, 1984. ~he aforementioned thermoplastic materials comprise a base polymer that is a block or segmented co-polymer thermoplastic with at least one block type which has an abrupt qlass transition temperature (Tg) at or greater than room temperature, but less than approximately body temperature. The remainder of the base polymer contains hard bloc~s whose dominant thermal transition is substantially greater than bodv temperature. The cannulae are originally made with their eventually desired -expanded internal diameter and then are heated above the glass transition ~T~, drawn out to form longer and thinner cannulae and held in this state until cooled below the (T~). Once the longer and thinner cannulae have warmed to a temperature that is greater than room temperature but less than approximately body temperature, i.e., once the cannulae have reached the glass transition temperature, T~, the shape-memory properties operate and the cannulae increase in internal and external diameter while shrinking in length.
Figures 2a and 2b illustrate an embodiment of the invention wherein the hub 214 has a passage-way 228 therethrough from a first end 230 to a second end 232 thereof. The passageway 228 has an inner surface 234 selected so that the passageway 228 has a cross-sectional area throughout which is at least substantially equal to 125% of the initial duct cross-section 224 and is preferably at least substantially equal to the enlarged duct cross-section 226 (Figure 2b). In the embodiment of Figures 2a and 2b this is accomplished by providing a counterbore 236 which extends inwardly from the .n~" ~
~Z~7~
first end 230 of the hub 214 coaxially with the passageway 22a and is of a sufficient size so that when the cannula 212 swells its cross-section in the counterbore 235 is at least equal to 125~ of the initial duct cross-section 224 and i5 preferab~y at least e~ual to the enlarged duct cross--section 226.
In such a situation the proximal end portion 218 of the cannula 212 is preshaped or preformed, as bv being pre-expanded, pre-mQlded or the like, and has substantially the aforementioned enlarged duct cross-section 226 and the proximal portion 218 is positioned within the passageway 22R at the first end 230 of the hub 214. The attaching means 216, in the embodiment of Figures 2a and 2b includes the i5 counterbore 236 of the passagewa~ 228 which extends inwardly from the first end 230 of the hub 214. The counterbore 236 is bonded to an outer surface 240 of the proximal end portion 218 of the cannula 212 by being insert injection molded, by solvent welding, by RF welding, using a bonding composition, or by any other appropriate technique. In the particular embodiment illustrated in Figure 2a the proximal end portion 18 of the cannula 212 has been preshaped, e.g., thermally, ~Intil it has a duct cross-section that equals or exceeds the enlarged cross-section 226 while the majoritv of the cannula 212 has not yet been expanded.
Adverting now to ~igures 3a, 3b and 3c, there is illustrated an embodiment of the present invention which includes the use of a hub insert 342. In the embodiment of Figure 3a the hub insert 342 has an opening 344 therethrough from a first end 346 to a second end 348 thereof. ~he opening 344 has an inner cross-section which is throughout at least suhstantially equal to 125% of the initial duct cross-section 324 and is preferably at least substantially equal to the enlargecl duct cross-section 326 (Figure 3c). A part 352 of the passageway 328 in the hub 314 aAjacent t:he first end 330 of the hub 314 has an inner surface which is geometrically similar to and positioned about an outer surface 356 of the hub insert 342. The part 352 of the passageway 328 and the outer surface 356 0 of the hub insert 3g2 are adapted to hold the proximal end portion 318 of the cannula 312 impressed therebetween. If desired, a bonding composition can be attached between the hub insert 342 and the duct 322 and/or between the part 352 of the passageway 328 and the outer surface of the proximal end portion 318 of the cannula 312.
Figure 3a illustrates an embodiment wherein the cannula 312 is in the non-expanded state and has not yet expanded through contact with a liquid or through being heated to between room temperature and hody temperature. The proximal end portion 318 of the cannula 312 has been forced over the hub insert 342, thus preshaping or preforming it only adjacent the hub insert 342. Alternati.vely, the proximal end portion 318 may be thermally or otherwise preshaped or preformed. Figure 3b is similar to Figure 3a but illustrates the cannula 312 as being preshaped interiorly and exterior~y of the hub 314 to have a duct cross-section that equals or exceeds the enlarged duct cross-section 326. Figure 3c illustrates the embodiment wherein the cannula 312 is in the expanded state.
Figure 4 illustrates an embodiment of the present invention wherein the attaching means 416 iL6~
includes a tapered outer surface 458 on the first end 430 of the hub 414 which tapers to a smallest dimension towards the cannula 412 and which holds the proximal end portion 418 of the cannula 412 thereabout in interference fit. If d~esired, a bonding compound can be placed between the inner surface of the cannula 412 and the tapered outer surface 458 on the first end 430 of the hub 414 or bonding may be accomplished bv insert injection ~olding of the parts, by solvent or RF welding, by using a bonding composition or by another appropriate technique, Figure 4 shows the cannula 412 in its non-expanded state. The cross-section of the passagew~y 428 is thorughout at least 125~ of the initial duct cross-section 424. Preferably in its expanded state the internal cross-section of the duct 422 expands to a size less than or equal to the smallest cross-section of the passageway 428.
Figures 5a, Sb and 5c illustrate embodiments closely related to the embodiment of Fiqure 4. These embodiments differ from the em'vdiment of Figure 4 in that the attaching means 516 further includes an outer member 560 having an opening 562 therethrough from a first end 564 to a second end 566 thereof. The opening 562 is generally geometrically similar to the tapered outer surface 558 of the first end 530 of the hub 514.
The outer member 560 is positioned about the tapered outer surface 558 of the first end 530 of the hub 514 with the inner surface of the opening 562 bearing against the outer surface 540 of the proximal end portion 518 of the cannula 512. The outer member 560 may engage with the hub 514 as by screwing thexeon, by solvent or RF welding, by using ~2S~
a bonding composition or by another appropriate technique. Figure 5a shows the cannula 512 in its non-expanded state while Figure 5b shows the cannula 512 in its expanded stateO Figure 5c illustrates the embodiment wherein the cannula 512 is in the non-expanded state but wherein the proximal end portion 518 of the cannula 512 has been preshaped so that its duct cross-section equals or exceeds the enlarged duct cross-section 526.
It will be noted that throughout the - various above described embodiments of the present invention the attaching means 216, 316, 416, 516 serves for attaching the proximal end portion 218, 318, 418, 518 of the cannula 212, 312, 412, 512 to the first end 230, 330, 430, 530 of the hub 214, 314, 414, 514 with the passageway 228, 328, 428, 528 through the hub 214, 314, 414, 514 in flow communication with the duct 222, 322, 422, 522 in the proximal end portion 218, 318, 418, 518 of the cannula 212, 312, 412, 512. Also, the attaching is in a manner such that the cross-section of the duct 222, 322, 422, 522 adjacent the proximal end portion 218, 318, 418, 518 thereof is throu~hout at least substantially equal to the enlarged duct cross-section 226, 326, 526 along the remainder of the cannula 212, 312, 412, 512 that results from exposure to body temperature and/or f l uid s .
Having the proximal end portion 218, 318, 413, 518, of the duct 222, 322, 422, 522, of the cannula 212, 312, 412, 512 be preshaped to be of larger cross-section than is the remainder of the cannula 212, 312, 412, 512 before insertion into a body is useful in that it allows the user of the catheter assembly 10 to visually observe just how big a cannula 212, 312, 412, 512 will be formed once expansion nas taken place (i.e., upon insertion into the ~ody). Furthermore, in certain instances it is easier to utilize the attaching means 216, 316, 416, 516 if the proximal end portion 218, 318, 418, 518 of the duct 222, 322, 422, 522 of the cannula 212, 312, 412, 51 is of lar~er cross-section than is the remainder of the cannula 212, 312, 412, 512.
Figures 6a and 6b illustrate an embodi~ent of the invention wherein the hub 614 and the cannula 612 are of integral construction with the first end 630 of the hub 614 integral with the proximal end portion 618 of the cannula 612 and with the duct 622 being a continuation of the passageway 628. In s~lch a structure the hub 614, like the cannula 612, is formulated of a material 3uch that an inner cross-section of the passageway 628 increases when at least a part of the distal end portion 20 of the ~ cannula 612 is inserted into a body of a living ; 20 subject and maintained in the body and/or when the passageway 628 or the duct 622 is contacted by an aqueous liquid, for a period of time sufficient ~or the enlarged duct cross-sect.on to form.
Accordingly, when the cannula 612 increases in cross-section so does the hub 614. The area which would correspond to the first end 630 of the hub 614, if the hub 614 was not integrally joined to the cannula 12, generally has a relatively thin wall so that it can increase in cross-section along with the area which would correspond to the proximal end portion 61R of the cannula 6~2. The second end 632 of the hub 614 generally has a thicker wall than the area which would correspond to ~he first end 63~ so that the passageway 628, adjacent the second end 632 of the hub 614, can retain connection about an input tube lnot shownl from a liquid source. A retaining ring 668 positioned about the second end 632 of the hub 614 can serve as means for preventing radial expansion thereof thus aiding in retention of connection about an input or output tube.
Industrial Applicability In accordance with the present invention a catheter assembly 10 is set forth which is useful for introduction of medication and nutrients to and/or extraction of body fluids from a patient.
Other aspects, objectives and advantages of the present invention can be obtained from a study of the drawin~s, the disclosure and the appended claims.
If such increasing duct cross-section cannulae as are discussed above are a~tached to the conventional hubs of the prior art the full effect 31 257~6~
of the increased duct cross-section, in ~low rate, cannot be realized because prior art hubs are such that flow will be limited either because of the size of the passageway through the hubs or because the hubs hold the cannulae in such a manner that instead of the cannulae proximal ends being held so that the duct cross section can increase, the cannulae are externally restrained whereby the duct cross-section is forced to decrease.
The present invention is directed to overcoming one or more of the problems as set forth above.
Disclosure Of The Invention One aspect of the present invention is a catheter assembly comprising a cannula having a proximal end portion, a distal end portion and a longitudinal duct therethrough, the cannula being of a material such that an inner cross-section of the duct increases to form an increased duct cross-section when at least a part of the distal end portion is inserte~ into a body of a living sub~ect and maintained in contact with the body, and/or when the duct is contacted by an a~ueous liquid, for a period of time sufficient for the enlarged duct cross-section to form. The catheter assemblv further includes a hub having a passageway therethrough from a first to a second end thereof, the passagewav having a cross-sectional area throughout at least substantiall~ equal to the enlarged duct cross-section. Attaching means are provided for attaching the proximal end portion of the cannula to the first end of the hub with the passageway through the hub in flow communication ,~, . ...
with the duct in the proximal end portion of the cannula, the attaching being in a manner such that the cross-sectional area of the duct adjacent the proximal end portion, following formation of the - 5 enlarged duct cross-section, is throughout at least substantially equal to the enlarged duct cross-section along the remainder of the cannula.
Another aspect of the present invention is a catheter assembly comprising a cannula having 10 proximal and distal end portions and a longitudinal duct therethrough, the cannula being of a material such that an inner cross-section of the duct increases to form an enlarged duct cross-section when at least a part of the distal end portion is 15 inserted into a body of a living subject and maintained there, and/or when the duct is contacted by an aqueous liquid, for a period of time sufficient for the enlarged cross-section to form.
The catheter assembly further comprises a hub having 20 a passageway therethrough from a first to a second end thereof, the passageway having a cross-sectional area throughout at least substantially equal to the enlarged duct cross-section, the first end of the hub and the proximal end portion of the cannula 25 being attached with the passageway and duct in flow communication, the attaching being in a manner such that the cross-sectional area of the duct adjacent the proximal end portion, following formation of the enlarged duct cross-section, is throughout at 30 least substantially equal to the enlarged duct cross-section along the remainder of the cannula.
Still another aspect of the present invention is a catheter assembly comprising a ~L~S~L6~i cannula having a proximal end portion, a distal end portion and a longitudinal duct therethrough, the duct haviny an initial inner cross-section which increases to form an increased duct cross-section when at least a part of the distal end portion of the cannula is inserted into a body of a living subject and maintained in contact with the body, and/or when the duct is contacted by an aqueous liquid, for a period of time sufficient for the enlarged duct cross-section to form. The catheter assembly further includes a hub having a paasageway therethrough from a first to a second end thereof, the passageway having a cross-sectional area throughout at least substantially equal to 125% of the initial inner cross-section of the duct.
Attaching means are provided for attaching the proximal end portion of the cannula to the first end of the hub with the passageway through the hub in flow communication with the duct in the proximal end portion of the cannula, the attaching being in a manner such that the cross-sectional area of the duct adjacent the proximal end portion, following formation of the enlarged duct cross-section, is throughout at least substantially equal to the cross-sectional area of the passageway.
Another aspect yet of the present invention is a catheter assembly comprising a cannula having proximal and distal end portions and a longitudinal duct therethrough, the duct having an initial inner cross-section which increases to form an enlarged duct cross-section when at least a part of the distal end portion of the cannula is inserted into a body of a living subject and maintained there, and/or when the duct is contacted by an ~s~
aqueous liquid, ~or a period of time sufficient for the enlarged cross-section to form. The catheter ~ssembly further comprises a hub having a passageway therethrough from a first to a second end thereof, the passageway having a cross~sectional area throughout at least substantially equal to 125% of the initial inner cross section of the duct, the first end of the hub and the pro~imal end portion of the cannula beinq attached with the passageway and duct in flow communication, the attaching being in a manner such that the cross-sectional area of the duct adjacent the proximal end portion, following ; formation of the enlarged duct cross-section, is throughout at least substantially equal to the cross-sectional area of the passageway.
Utilizing a catheter assembly in accordance with the present invention one can take full advantage of the enlarged duct cross-section in the cannula whereby one can utilize smaller steel needles and cannulae for insertion into the body to attain a throughput equal to that attained utilizing such relatively larger needles as are currently in use ox, alternatively, one can utili7e steel needles and cannulae of the size presentlv used an~ can ~hereby attain a much higher throu~hput.
Brief Description_Of The Drawings The invention will be better understood by reference to the figures of the drawings wherein like numbers denote like parts throughout and wherein:
Figure 1 is a perspective view of a catheter assembly in accordance with an embodiment of the present invention;
Figure 2a is a cross-sectional view of an embodiment of a hub and the preshaped proximal end portion of a cannula in accordance with an embodiment of the present invention in a non-expanded state;
~ Figure 2b is a ~iew similar to Figure 2a hut with the cannula in the expanded state;
Figure 3a is a view similar to Figure 2a but showing an alt~rnate embodiment of a catheter assembly in accordance with the present invention with the cannula in the non-expanded state;
Fiyure 3b is a view similar to Fi~ure 3a but with the cannula proximal end portion preshaped;
Figure 3c is a view similar to Figure 3a but with the cannula in the expanded s,tate;
Figure 4 illustrates, in a view similar to Figure 2a, another alternate embodiment in accordance with the present invention;
Figure 5a illustrates another embodiment yet of the present invention with the cannula in a non-expanded state;
Figure Sb illustrates a view similar to Figure 5a but with the cannula in its expanded state;
Fi~ure 5c illustrates an alternate embodiment of the present invention similar to ihat of Figure Sa but wherein the cannula has been preshaped at its proximal end portion;
: Figure 6a illustrates vet another embodiment of the present invention wherein the hub and cannula are o integral construction in the non-expanded state; and Figure 6b illustrates the embodiment of Figure 6a with the hub and cannula in the expanded state.
~est Mode For Carrying ~ut The Invention _ In the following description corre~ponding parts of the structures called out are clistinguished from one embodiment to another by preceeding the number of the part with the number of the Figure.
Thus, for example, part 216 in Figure 2 corresponds to part 316 in Figure 3, part 416 in Figure 4, part 516 in Figure 5, and part 616 in Figure 6. The fol Iowing discussion is directed to an over the ne~dle type of catheter assembly 10. However, while the discussion is limited in this manner such ~imitation is for convenience only. Thus, cannulae which are long tubes and short tubes, catheter assemblies which are inserted by other than an over the needle techniaue, and the like, also fall within the scope of the invention.
~he invention relates to a catheter assembly 10, one embodiment of which is seen~ in perspective in Figure 1. The catheter assembly 10 inc~udes a cannula 12 along with a hub 14 and attaching means 216, 316, 416 and 516 (seen in Figures 2-6). The cannula 1~ has a proximal end portion 18 and a distal end portion 20. A
longitudinal duct 222, 322, 422, 522 and 622 (Figures 2-6) is defined within the cannula 12 and extends therethrough from the proximal end portion 18 ~o the distal end portion 20. It is essential to the practice of the present invention that the cannula 12 be formulated of a material selected such that an inner cross-sectional area (at 224, 324, ~2~
_ 9 424, 524, 624) of the duct 222, 322, 422, 522, 62 increases to form an enlarged duct cross-sectional area (at 226, 326, 526, 626), generally enlarged from at least about 25~ Ito 125~ of its initial inner cross-section) to at least about 300%, preferably from about 40% to about 300%; for over the needle cannulae the enlargement is more preferably from about 35% to about 140% and most preferably from about 40% to about 100%; when at least a part of the distal end portion 20 of the cannula 12 is inserted into a body, generally into the blood stream, of a living subiect and maintained in contact with that body, and/or when the duct 22?, 322, 422, 522, 622 is contacted by, e.~., filled with, an aqueous liquid, for a time sufficient for the enlarged duct cross-section ~at 226, 326, 426, 526) to form.
In accordance with a preferred embodiment : of the present invention the cannula comprises a multiple phase polymeric composition comprising a first phase which comprises a substantially non-hydrophilic polymeric component and a second phase which comprises a hydrophilic polymeric component. The relative amounts of these components are selected, depending on the particular polymeric materials employed, to provide a composition havin~
the desired properties, as discussed more fully below.
Preferably the non-hydrophilic polymeric component forms a continuous phase. The hydrophilic polymeric component can form a co-continuous phase with, or a dispersed phase in, the non-hydrophilic po1ymer phase.
The non-hydrophilic polymeric component comprises a polymer which does not substanti~lly absorb or attract water. Preferably, the non-hydrophilic poIymer is capahle of absorbing in 5 an amount of no more than about 30~, more preferably no more than about 15%, and most preferably no more than about 10%, by weight, based on the weight of the non-hydrophilic polymer.
The non-hydrophilic polymer can be for example, a polyurethane such as an aliphatic polyurethane, a polyether polyurethane, a polvester polyurethane; an ethylene copolymer such as ethylene-vinyl acetate copolymer or ethylene-ethyl acrylate copolymer; a polyamide, in particular a polyamide of low crystallinity; an aliphatic polyester; or the like. A particularly preferred non-hydrophilic polymer is a polyurethane, especially an aliphatic polyurethane.
The hydrophilic po1ymer preferably is a polymer that absorbs at least about 50~ water, more preferably about 100~, for example, at least about 150~, by weight based on the weight of the hydrophilic polymer. The hydrophilic polymer preferably forms a hydrogel on absorption of water.
The hydrophilic polymer is preferably polyvinyl alcohol, poly(ethylene oxide), polypropylene oxide, poly(ethylene glvcol), polypropylene glycol, polytetramethylene oxide, polyvinyl pyrolidene, polyacrylamide, poly(hydroxy-ethyl acrylate), poly(hydroxyethyl methacrylate), or the like.
The multiple phase composition can be prepared by ~ixing the polymeric co~ponents or by forminq a block or ~raft copolymer containing the polymeric components. A mixture of the components can be prepared using, for example, a two-roll mill, an internal mixer, such as a Brabender or Banbur~
mixer, an extruder , e.g., twin-screw e~truder, or S the like. Block and graft copolymers can be prepared by appropriate methods depending on the particular nature of the components used. Typical preparatory methods can be found, for example, in "Block and Graft Copolymerization", R.J. Ceresa ~Zd) r 1973, Vol. 1 & 2, Wiley-Interscience, New York and "Block Copolymers", D.C. A~lport and W.H. Jane, 1973, Wiley, New York.
Generally, the ratio of non-hydrophilic polymeric component to hydrophilic polymeric component is 0.65:1 to 9:1. Preferably the ratio of the polymeric components is 1:1 to 9:1.
The polymeric components are selected to provide a multiple phase system. Generally, the polymeric components each have a mo]ecular weight of at least about 3,000 preferably at least about 5,000 and most preferably at least about 10,000.
As stated above, the relative amounts of non-hydrophilic and hydrophilic polymeric components are selected, depen~ing on the particular materials employed, to provide the desired properties. Due to the presence of the hydrophilic poly~eric component, the composition is capable of being hydrated by the absorption of water. As water is absorbed by the composition, it may soften with a so tening ratio of at least about 2:1, preferably at least 6:1, more preferably at least about 10:1, most preferably at least about 20:1, and in particular at about 40:1.
The term "softening ratio" is used herein to refer to the ratio of the 2.5% Secant modulus values of the composition, in the form of a tubular article, when substantially non-hydrated, to the 2.5~ Secant modulus of the composition when substantial~v completely hydrated. The term "substantially non-hydrated" refers to the state of the composition undex conventional ambient conditions, i.e., room temperature, 50-80% relative humi~ity and about atmospheric pressure. The term "substantially completely hydrated" refers to the state of the composition when it is in equilibrium with an excess of water at 37C and ambient pressure.
The composition may swell on absorption of water with a swelling ratio of at least about 1.3:1, preferably at least about 1.7:1 and most preferably at least about 2.0:1. The term "swelling ratio"
refers to the ratio of the volume of a ~iven sample of the composition when substantially completely hydrated to its volume when substantially non-hydrated.
Preferably the composition both softens and swells when placed in the body.
When substantially completely hydrated the composition has a tensile energy to break of at least about 700 Newton-centimeters per cubic centimeter (N-cm/cm3), preferably at least about 1,400 N-cm/cm and most preferably about 1,700 N-cm/cm . The term "tensile energy to break" (T~
is defined in ASTM-D882 as the area under the stress-strain curve or ... ~ . ... . . ~ ..
~2 ~
TEB = 5 Sd~
o where S is the stress at any strain, ~ ,; and ~
is the strain at rupture. The tensile energy to break provides an indication of the toughness of the hydrated composition and its ability to withstand the conditions it will be subjected to in use.
It will be readily appreciated that when a tubular product such as a cannula is withdrawn from the body it is extremely important that it does not tear or break leaving piece~ remaining inside the hody. Neither tensile strength nor elon~ation to break are good indicators of toughness. Brittle materials and notch sensitive materials can have tensile strengths~ Extremely weak materials can have high elon~ation but not the strength to survive extraction. TEB i5 a measure of the energy required to break and is a combination of these-two important criteria.
The ultimate elongation of the multiple phase composition should be at least about lO~, preferably at least about 25~ and most preferablv at least about 50~.
The composition when substantially completely hydrated has a 2.5~ Secant modulus of less than about 7,000 Newtons/s~uare centimeter ~N/cm2), preferably less than-about 3,500 N/cm2 and most preferably less than about 2,000 N/cm2. ~hen substantially completely hy~rated the 2.5~ Secant 3L;2~;7~
modulus can be as low as about 30 N/cm2 but preferably above about 60 N/cm2 and most preferahly above about 120 N/cm2.
Typically the 2.s% Secant modulus of the composition when substantially non-hydrated is at least about 20,000 N/cm2 when used as over the needle catheter in accordance with the present invention. Preferably the 2.5% ~ecant modulus of the composition is at least about ~8,000 N/cm2.
The composition may be crosslinked if desired. Crosslinking of the composition gives the polymeric composition strength above the melting or softening points of the polymeric components permitting steriliæation of a device utilizing the ~5 composition at above that temperature. This is particul~rly advantageous if the polymeric component of the continuous phase has a relatively low melting or softening point. Crosslinking of the composition may also be used to adjust the 2.5% Secant modulus of the composition to bring it to the desir~d value for the proposed use of the composition. When the composition comprises a physical mixture of the non hydrophilic and hydrophilic components, crosslinking of the mixture can controi the tendency of the hydrophilic component to leach out of the composition when it is in extended contact with water or body fluids. Crosslinking may also improve the toughness ~TEB) of the composition in the hydrated state.
Crosslinking of the composition can be effected by use of an appropriate crosslinking agent or by irradiation, preferably in the presence of a crosslinking promoter, such as triallyl isocyanurate, or the like. In a preferred embodiment the composition is crosslinked by high energy radiation from an electro~ accelerator. The amount of irradiation should be in the range of about 0.5 to about 30 ~egarads (Mrads) preferably about 0.5 to about 15 Mrads and most preferably about 0.5 to ~bout 10 Mrads.
Either or both components of the composition may contain additional ingrec7ients such as stabilizers, antioxidants, radiopacifiers, medicaments, fillers or the like. For certain applications it may be advantageous to incorporate a water soluble or water dispersible medicament which can leach from the composition of the cannula when it contacts body fluids. Such medicaments include anti-thrombogenic agents, antibiotics, anti-viral agents, anticoa~ulants, anti-inflammatory agents or the like.
The cannula should not swell or soften appreciably during the time it is being inserted in a vein or the like. It has been found that the time for the cannula to swell to 50% of its fully swollen volume should be at least ahout 15 seconds, prefera~ly at least about 60 seconds.
An alternative material which may be utilized as the cannula material is a thermoplastic material with shape-memory properties. Such polymeric compounds are described, for example, in the following articles: Softenable, Shape-Memory Thermoplastics For Biomedical ~7se, Robert S. Ward, MD7D, August 1985; and Thromboresistant, Radiopaquer Softenable Thermoplastic Catheter Compound With Shape-Memory Properties, R.S. Ward, K.A. White, J~S.
P.iffle, Second World Congress On Biomaterials, 10th Annual Meeting Of The Society For ~iomaterials, J ., I ~ ~ f .-~IL25~7~66 - lfi Washington, D.C., April 27-May 1, 1984. ~he aforementioned thermoplastic materials comprise a base polymer that is a block or segmented co-polymer thermoplastic with at least one block type which has an abrupt qlass transition temperature (Tg) at or greater than room temperature, but less than approximately body temperature. The remainder of the base polymer contains hard bloc~s whose dominant thermal transition is substantially greater than bodv temperature. The cannulae are originally made with their eventually desired -expanded internal diameter and then are heated above the glass transition ~T~, drawn out to form longer and thinner cannulae and held in this state until cooled below the (T~). Once the longer and thinner cannulae have warmed to a temperature that is greater than room temperature but less than approximately body temperature, i.e., once the cannulae have reached the glass transition temperature, T~, the shape-memory properties operate and the cannulae increase in internal and external diameter while shrinking in length.
Figures 2a and 2b illustrate an embodiment of the invention wherein the hub 214 has a passage-way 228 therethrough from a first end 230 to a second end 232 thereof. The passageway 228 has an inner surface 234 selected so that the passageway 228 has a cross-sectional area throughout which is at least substantially equal to 125% of the initial duct cross-section 224 and is preferably at least substantially equal to the enlarged duct cross-section 226 (Figure 2b). In the embodiment of Figures 2a and 2b this is accomplished by providing a counterbore 236 which extends inwardly from the .n~" ~
~Z~7~
first end 230 of the hub 214 coaxially with the passageway 22a and is of a sufficient size so that when the cannula 212 swells its cross-section in the counterbore 235 is at least equal to 125~ of the initial duct cross-section 224 and i5 preferab~y at least e~ual to the enlarged duct cross--section 226.
In such a situation the proximal end portion 218 of the cannula 212 is preshaped or preformed, as bv being pre-expanded, pre-mQlded or the like, and has substantially the aforementioned enlarged duct cross-section 226 and the proximal portion 218 is positioned within the passageway 22R at the first end 230 of the hub 214. The attaching means 216, in the embodiment of Figures 2a and 2b includes the i5 counterbore 236 of the passagewa~ 228 which extends inwardly from the first end 230 of the hub 214. The counterbore 236 is bonded to an outer surface 240 of the proximal end portion 218 of the cannula 212 by being insert injection molded, by solvent welding, by RF welding, using a bonding composition, or by any other appropriate technique. In the particular embodiment illustrated in Figure 2a the proximal end portion 18 of the cannula 212 has been preshaped, e.g., thermally, ~Intil it has a duct cross-section that equals or exceeds the enlarged cross-section 226 while the majoritv of the cannula 212 has not yet been expanded.
Adverting now to ~igures 3a, 3b and 3c, there is illustrated an embodiment of the present invention which includes the use of a hub insert 342. In the embodiment of Figure 3a the hub insert 342 has an opening 344 therethrough from a first end 346 to a second end 348 thereof. ~he opening 344 has an inner cross-section which is throughout at least suhstantially equal to 125% of the initial duct cross-section 324 and is preferably at least substantially equal to the enlargecl duct cross-section 326 (Figure 3c). A part 352 of the passageway 328 in the hub 314 aAjacent t:he first end 330 of the hub 314 has an inner surface which is geometrically similar to and positioned about an outer surface 356 of the hub insert 342. The part 352 of the passageway 328 and the outer surface 356 0 of the hub insert 3g2 are adapted to hold the proximal end portion 318 of the cannula 312 impressed therebetween. If desired, a bonding composition can be attached between the hub insert 342 and the duct 322 and/or between the part 352 of the passageway 328 and the outer surface of the proximal end portion 318 of the cannula 312.
Figure 3a illustrates an embodiment wherein the cannula 312 is in the non-expanded state and has not yet expanded through contact with a liquid or through being heated to between room temperature and hody temperature. The proximal end portion 318 of the cannula 312 has been forced over the hub insert 342, thus preshaping or preforming it only adjacent the hub insert 342. Alternati.vely, the proximal end portion 318 may be thermally or otherwise preshaped or preformed. Figure 3b is similar to Figure 3a but illustrates the cannula 312 as being preshaped interiorly and exterior~y of the hub 314 to have a duct cross-section that equals or exceeds the enlarged duct cross-section 326. Figure 3c illustrates the embodiment wherein the cannula 312 is in the expanded state.
Figure 4 illustrates an embodiment of the present invention wherein the attaching means 416 iL6~
includes a tapered outer surface 458 on the first end 430 of the hub 414 which tapers to a smallest dimension towards the cannula 412 and which holds the proximal end portion 418 of the cannula 412 thereabout in interference fit. If d~esired, a bonding compound can be placed between the inner surface of the cannula 412 and the tapered outer surface 458 on the first end 430 of the hub 414 or bonding may be accomplished bv insert injection ~olding of the parts, by solvent or RF welding, by using a bonding composition or by another appropriate technique, Figure 4 shows the cannula 412 in its non-expanded state. The cross-section of the passagew~y 428 is thorughout at least 125~ of the initial duct cross-section 424. Preferably in its expanded state the internal cross-section of the duct 422 expands to a size less than or equal to the smallest cross-section of the passageway 428.
Figures 5a, Sb and 5c illustrate embodiments closely related to the embodiment of Fiqure 4. These embodiments differ from the em'vdiment of Figure 4 in that the attaching means 516 further includes an outer member 560 having an opening 562 therethrough from a first end 564 to a second end 566 thereof. The opening 562 is generally geometrically similar to the tapered outer surface 558 of the first end 530 of the hub 514.
The outer member 560 is positioned about the tapered outer surface 558 of the first end 530 of the hub 514 with the inner surface of the opening 562 bearing against the outer surface 540 of the proximal end portion 518 of the cannula 512. The outer member 560 may engage with the hub 514 as by screwing thexeon, by solvent or RF welding, by using ~2S~
a bonding composition or by another appropriate technique. Figure 5a shows the cannula 512 in its non-expanded state while Figure 5b shows the cannula 512 in its expanded stateO Figure 5c illustrates the embodiment wherein the cannula 512 is in the non-expanded state but wherein the proximal end portion 518 of the cannula 512 has been preshaped so that its duct cross-section equals or exceeds the enlarged duct cross-section 526.
It will be noted that throughout the - various above described embodiments of the present invention the attaching means 216, 316, 416, 516 serves for attaching the proximal end portion 218, 318, 418, 518 of the cannula 212, 312, 412, 512 to the first end 230, 330, 430, 530 of the hub 214, 314, 414, 514 with the passageway 228, 328, 428, 528 through the hub 214, 314, 414, 514 in flow communication with the duct 222, 322, 422, 522 in the proximal end portion 218, 318, 418, 518 of the cannula 212, 312, 412, 512. Also, the attaching is in a manner such that the cross-section of the duct 222, 322, 422, 522 adjacent the proximal end portion 218, 318, 418, 518 thereof is throu~hout at least substantially equal to the enlarged duct cross-section 226, 326, 526 along the remainder of the cannula 212, 312, 412, 512 that results from exposure to body temperature and/or f l uid s .
Having the proximal end portion 218, 318, 413, 518, of the duct 222, 322, 422, 522, of the cannula 212, 312, 412, 512 be preshaped to be of larger cross-section than is the remainder of the cannula 212, 312, 412, 512 before insertion into a body is useful in that it allows the user of the catheter assembly 10 to visually observe just how big a cannula 212, 312, 412, 512 will be formed once expansion nas taken place (i.e., upon insertion into the ~ody). Furthermore, in certain instances it is easier to utilize the attaching means 216, 316, 416, 516 if the proximal end portion 218, 318, 418, 518 of the duct 222, 322, 422, 522 of the cannula 212, 312, 412, 51 is of lar~er cross-section than is the remainder of the cannula 212, 312, 412, 512.
Figures 6a and 6b illustrate an embodi~ent of the invention wherein the hub 614 and the cannula 612 are of integral construction with the first end 630 of the hub 614 integral with the proximal end portion 618 of the cannula 612 and with the duct 622 being a continuation of the passageway 628. In s~lch a structure the hub 614, like the cannula 612, is formulated of a material 3uch that an inner cross-section of the passageway 628 increases when at least a part of the distal end portion 20 of the ~ cannula 612 is inserted into a body of a living ; 20 subject and maintained in the body and/or when the passageway 628 or the duct 622 is contacted by an aqueous liquid, for a period of time sufficient ~or the enlarged duct cross-sect.on to form.
Accordingly, when the cannula 612 increases in cross-section so does the hub 614. The area which would correspond to the first end 630 of the hub 614, if the hub 614 was not integrally joined to the cannula 12, generally has a relatively thin wall so that it can increase in cross-section along with the area which would correspond to the proximal end portion 61R of the cannula 6~2. The second end 632 of the hub 614 generally has a thicker wall than the area which would correspond to ~he first end 63~ so that the passageway 628, adjacent the second end 632 of the hub 614, can retain connection about an input tube lnot shownl from a liquid source. A retaining ring 668 positioned about the second end 632 of the hub 614 can serve as means for preventing radial expansion thereof thus aiding in retention of connection about an input or output tube.
Industrial Applicability In accordance with the present invention a catheter assembly 10 is set forth which is useful for introduction of medication and nutrients to and/or extraction of body fluids from a patient.
Other aspects, objectives and advantages of the present invention can be obtained from a study of the drawin~s, the disclosure and the appended claims.
Claims (32)
1. A catheter assembly, comprising:
a unitary cannula having a proximal end portion, a distal end portion, and a longitudinal duct therethrough from the proximal end portion to the distal end portion, the cannula being of a polymeric material selected such and having the intrinsic property that an inner cross-section of the duct increases to form an enlarged duct cross-section when at least a part of the distal end portion of the cannula is inserted into a body of a liking subject and maintained in said body, and/or when the duct is contacted by an aqueous liquid for a period of time sufficient for the enlarged duct cross-section to form;
a hub having a passageway therethrough from a first to a second end thereof, said passageway having a cross-sectional area throughout at least substantially equal to the enlarged duct cross-section; and attaching means for attaching said proximal end portion of said cannula to said first end of said hub with said passageway through said hub in flow communications with said duct in said proximal end portion of said cannula, said attaching being in a manner such that the cross-sectional area of the duct adjacent the proximal end portion, following formation of the enlarged duct cross-section, is throughout at least substantially equal to the enlarged duct cross-section along the remainder of the cannula.
a unitary cannula having a proximal end portion, a distal end portion, and a longitudinal duct therethrough from the proximal end portion to the distal end portion, the cannula being of a polymeric material selected such and having the intrinsic property that an inner cross-section of the duct increases to form an enlarged duct cross-section when at least a part of the distal end portion of the cannula is inserted into a body of a liking subject and maintained in said body, and/or when the duct is contacted by an aqueous liquid for a period of time sufficient for the enlarged duct cross-section to form;
a hub having a passageway therethrough from a first to a second end thereof, said passageway having a cross-sectional area throughout at least substantially equal to the enlarged duct cross-section; and attaching means for attaching said proximal end portion of said cannula to said first end of said hub with said passageway through said hub in flow communications with said duct in said proximal end portion of said cannula, said attaching being in a manner such that the cross-sectional area of the duct adjacent the proximal end portion, following formation of the enlarged duct cross-section, is throughout at least substantially equal to the enlarged duct cross-section along the remainder of the cannula.
2. A catheter assembly as set forth in claim 1, wherein the increase in the duet cross-section is at least about 25%.
3. A catheter assembly as set forth in claim 1, wherein the proximal end portion of the cannula has the enlarged duet cross-section preformed thereat and the cannula is positioned within the passageway at the first end of the hub and wherein the attaching means includes a part of the passageway extending inwardly from the first end of the hub having an inner surface bonded to an outer surface of the proximal end portion of the cannula having the enlarged duct cross-section.
4. A catheter assembly as set forth in claim 1, wherein the attaching means includes (1) a hub insert having an opening therethrough from a first end to a second end thereof, said opening having an inner cross-sectional area which is throughout at least substantially equal to the enlarged duct cross-section and (2) a part of the passageway adjacent the first end of the hub, the part of the passageway having an inner surface geometrically similar to and positioned about an outer surface of the hub insert, the part of the passageway and the outer surface of the hub insert being adapted to hold the proximal end portion of the cannula in pressed or bonded fit therebetween.
5. A catheter assembly as set forth in claim 1, wherein said attaching means includes a tapered outer surface on said first end of said hub tapering to a smallest dimension towards said cannula and holding said proximal end portion of said cannula thereabout.
6. A catheter assembly as set forth in claim 5, including means bonding said tapered outer surface to said duct at said proximal end portion of said cannula.
7. A catheter assembly as set forth in claim 5, wherein said attaching means further includes an outer member having an opening therethrough from a first end to a second end thereof, said opening having an inner surface which is generally geometrically similar to said tapered outer surface of said first end of said hub, said outer member being positioned about said tapered outer surface of said first end of said hub with said inner surface thereof bearing against said outer surface of said proximal end portion of said cannula.
8. A catheter assembly as set forth in claim 1, wherein said proximal end portion of said duct of said cannula is preformed to be of larger cross section than i 5 the remainder of said cannula.
9. A catheter assembly as set forth in claim 1, wherein said material of said cannula comprises:
(a) a first phase which comprises a substantially non-hydrophilic polymeric component; and (b) a second phase which comprises a hydrophilic polymeric component;
said material (i) being capable of absorbing water to an extent that it softens with a softening ratio of at least about 2:1 and/or swells with a swelling ratio of at least about 1.3:1; and (ii) when substantially completely hydrated, having an energy to break of at least about 700 N-cm/cm3 and a 2.5% Secant modulus of less than about 7,000 N/cm2.
(a) a first phase which comprises a substantially non-hydrophilic polymeric component; and (b) a second phase which comprises a hydrophilic polymeric component;
said material (i) being capable of absorbing water to an extent that it softens with a softening ratio of at least about 2:1 and/or swells with a swelling ratio of at least about 1.3:1; and (ii) when substantially completely hydrated, having an energy to break of at least about 700 N-cm/cm3 and a 2.5% Secant modulus of less than about 7,000 N/cm2.
10. A catheter assembly as set forth in claim 1, wherein said material of said cannula comprises a thermo-plastic compound with shape-memory properties and with a glass transition temperature of greater than room temperature but less than about body temperature.
11. A catheter assembly as set forth in claim 1, wherein said cannula is of a plastic material.
12. A catheter assembly as set forth in claim 1, wherein said cannula has an unbroken wall.
13. A catheter assembly, comprising:
a unitary cannula having a proximal end portion, a distal end portion, and a longitudinal duct therethrough from the proximal end portion to the distal end portion, the cannula being of a polymeric material selected such and having the intrinsic property that an inner cross-section of the duct increases to form an enlarged duct cross-section when at least a part of the distal end portion of the cannula is inserted into a body of a living subject and maintained in said body, and/or when the duct is contacted by an aqueous liquid, for a period of time sufficient for the enlarged duct cross-section to form; and a hub having a passageway therethrough from a first to a second end thereof, said passageway having a cross-sectional area throughout at least substantially equal to the enlarged duct cross-section, said first end of said hub being attached to said proximal end portion of said cannula with said passageway through said hub in flow communication with said duct in said proximal end portion of said cannula, said attaching being in a manner such that the cross-sectional area of the duct adjacent the proximal end portion, following formation of the enlarged duct cross-section, is throughout at least substantially equal to the enlarged duct cross-section along the remainder of the cannula.
a unitary cannula having a proximal end portion, a distal end portion, and a longitudinal duct therethrough from the proximal end portion to the distal end portion, the cannula being of a polymeric material selected such and having the intrinsic property that an inner cross-section of the duct increases to form an enlarged duct cross-section when at least a part of the distal end portion of the cannula is inserted into a body of a living subject and maintained in said body, and/or when the duct is contacted by an aqueous liquid, for a period of time sufficient for the enlarged duct cross-section to form; and a hub having a passageway therethrough from a first to a second end thereof, said passageway having a cross-sectional area throughout at least substantially equal to the enlarged duct cross-section, said first end of said hub being attached to said proximal end portion of said cannula with said passageway through said hub in flow communication with said duct in said proximal end portion of said cannula, said attaching being in a manner such that the cross-sectional area of the duct adjacent the proximal end portion, following formation of the enlarged duct cross-section, is throughout at least substantially equal to the enlarged duct cross-section along the remainder of the cannula.
14. A catheter assembly as set forth in claim 13, wherein the increase in the duct cross-section is at least about 25%.
15. A catheter assembly as set forth in claim 13, wherein said first end of said hub is integral with said proximal end portion of said cannula and said duct is a continuation of said passageway, said first end of said hub having a lesser wall thickness than said second end of said hub, and said hub is formulated of a hub material selected such that an inner cross-section of the passageway increases when at least a part of the distal end portion of the cannula is inserted into a body of a living subject and maintained in said body, and/or when the passageway or the duct is contacted by an aqueous liquid, for a period of time sufficient for the enlarged duct cross-section to form.
16. A catheter assembly as set forth in claim 15, further including:
radial expansion preventing means for preventing radial expansion of said second end of said hub.
radial expansion preventing means for preventing radial expansion of said second end of said hub.
17. A catheter assembly as set forth in claim 15, wherein the material of said cannula and said hub material are each independently either:
I. a first composition comprising:
(a) first phase which comprises a substantially non-hydrophilic polymeric component, and (b) a second phase which comprises a hydrophilic polymeric component, said first composition (i) being capable of absorbing water to an extent that it softens with a softening ratio of at least about 2:1 and/or swells with a swelling ratio of at least about 1.3.1 and (ii) when substantially completely hydrated, having an energy to break of at least about 700 N-cm/cm3 and a 2.5% Secant modulus of less than about 7,000 N/cm; or II. a second composition comprising:
a thermoplastic compound with shape-memory properties and a glass transition temperature of greater than room temperature but less that about body temperature.
I. a first composition comprising:
(a) first phase which comprises a substantially non-hydrophilic polymeric component, and (b) a second phase which comprises a hydrophilic polymeric component, said first composition (i) being capable of absorbing water to an extent that it softens with a softening ratio of at least about 2:1 and/or swells with a swelling ratio of at least about 1.3.1 and (ii) when substantially completely hydrated, having an energy to break of at least about 700 N-cm/cm3 and a 2.5% Secant modulus of less than about 7,000 N/cm; or II. a second composition comprising:
a thermoplastic compound with shape-memory properties and a glass transition temperature of greater than room temperature but less that about body temperature.
18. A catheter assembly as set forth in claim 13, wherein said polymeric material is a plastic.
19. A catheter assembly as set forth in claim 13, wherein said cannula has an unbroken wall.
20. A catheter assembly, comprising:
a unitary polymeric cannula having a proximal end portion, a distral end portion, and a longitudinal duct therethrough from the proximal end portion to the distal end portion the duct having an initial inner cross-section which intrinsically increases to Eorm an enlarged duct cross-section when at least a part of the distal end portion of the cannula is inserted into a body of a living subject and maintained in said body, and/or when the duct is contacted by an aqueous liquid, for a period of time sufficient for the enlarged duct cross-section to form;
a hub having a passageway therethrough from a first to a second end thereof, said passageway having a cross sectional area throughout at least substantially equal to 125% of the initial inner cross-section of the duct; and attaching means for attaching said proximal end portion of said cannula to said first end of said hub with said passageway through said hub in flow communication with said duct in said proximal end portion of said cannula, said attaching being in a manner such that the cross-sectional area of the duct adjacent the proximal end portion, following formation of the enlarged duct cross-section, is throughout at least substantially equal to the cross-sectional area of the passageway.
a unitary polymeric cannula having a proximal end portion, a distral end portion, and a longitudinal duct therethrough from the proximal end portion to the distal end portion the duct having an initial inner cross-section which intrinsically increases to Eorm an enlarged duct cross-section when at least a part of the distal end portion of the cannula is inserted into a body of a living subject and maintained in said body, and/or when the duct is contacted by an aqueous liquid, for a period of time sufficient for the enlarged duct cross-section to form;
a hub having a passageway therethrough from a first to a second end thereof, said passageway having a cross sectional area throughout at least substantially equal to 125% of the initial inner cross-section of the duct; and attaching means for attaching said proximal end portion of said cannula to said first end of said hub with said passageway through said hub in flow communication with said duct in said proximal end portion of said cannula, said attaching being in a manner such that the cross-sectional area of the duct adjacent the proximal end portion, following formation of the enlarged duct cross-section, is throughout at least substantially equal to the cross-sectional area of the passageway.
21. A catheter assembly as set forth in claim 20, wherein the increase in the duck cross-section is from about 25% to about 200%.
22. A catheter assembly as set forth in claim 20, wherein said material of said cannula comprises:
(a) a first phase which comprises a substantially non-hydrophilic polymeric component; and (b) a second phase which comprises a hydrophilic polymeric component;
said material (i) being capable of absorbing water to an extent that it softens with a softening ratio of at least about 2:1 and/or swells with a swelling ratio of at least about 1.3:1; and (ii) when substantially completely hydrated, having an energy to break of at least about 700 N-cm/cm3 and a 2.5% Secant modulus of less than about 7,000 N/cm2.
(a) a first phase which comprises a substantially non-hydrophilic polymeric component; and (b) a second phase which comprises a hydrophilic polymeric component;
said material (i) being capable of absorbing water to an extent that it softens with a softening ratio of at least about 2:1 and/or swells with a swelling ratio of at least about 1.3:1; and (ii) when substantially completely hydrated, having an energy to break of at least about 700 N-cm/cm3 and a 2.5% Secant modulus of less than about 7,000 N/cm2.
23. A catheter assembly as set forth in claim 20, wherein said material of said cannula comprises a thermo-plastic compound with shape-memory properties and with a glass transition temperature of greater than room temperature but less than about body temperature.
24. A catheter assembly as set forth in claim 20, wherein said cannula is of a plastic material.
25. A catheter assembly as set forth in claim 20, wherein said cannula has an unbroken wall.
26. A catheter assembly, comprising:
a unitary polymeric cannula having a proximal end portion, a distal end portion, and a longitudinal duct therethrough from the proximal end portion to the distal end portion, the duct having an initial inner cross-section which intrinsically increases to form an enlarged duct cross-section when at least a part of the distal end portion of the cannula is inserted into a body of a living subject and maintained in said body, and/or when the duck is contacted by an aqueous liquid, for a period of time sufficient for the enlarged duct cross-section to form; and a hub having a passageway therethrough from a first to a second end thereof, said passageway having a cross-sectional area throughout at least substantially equal to 125% of the initial inner cross-section, said first end of said hub being attached to said proximal end portion of said cannula with said passageway through said hub in flow communication with said duct in said proximal end portion of said cannula, said attaching being in a manner such that the cross-sectional area of the duct adjacent the proximal end portion, following formation of the enlarged duct cross-section, is throughout at least substantially equal to the cross-sectional area of the passageway.
a unitary polymeric cannula having a proximal end portion, a distal end portion, and a longitudinal duct therethrough from the proximal end portion to the distal end portion, the duct having an initial inner cross-section which intrinsically increases to form an enlarged duct cross-section when at least a part of the distal end portion of the cannula is inserted into a body of a living subject and maintained in said body, and/or when the duck is contacted by an aqueous liquid, for a period of time sufficient for the enlarged duct cross-section to form; and a hub having a passageway therethrough from a first to a second end thereof, said passageway having a cross-sectional area throughout at least substantially equal to 125% of the initial inner cross-section, said first end of said hub being attached to said proximal end portion of said cannula with said passageway through said hub in flow communication with said duct in said proximal end portion of said cannula, said attaching being in a manner such that the cross-sectional area of the duct adjacent the proximal end portion, following formation of the enlarged duct cross-section, is throughout at least substantially equal to the cross-sectional area of the passageway.
27. A catheter assembly as set forth in claim 26, wherein the increase in the duct cross-section is from about 25% to about 300%.
28. A catheter assembly as set forth in claim 26, wherein said first end of said hub is integral with said proximal end portion of said cannula and said duct is a continuation of said passageway, said first end of said hub having a lesser wall thickness than said second end of said hub, and said passageway has an inner cross section which increases when at least a part of the distal end portion of the cannula is inserted into a body of a living subject and maintained in said body, and/or when the passageway or the duct is contacted by an aqueous liquid, for a period of time sufficient for the enlarged duct cross-section to form.
29. A catheter assembly as set forth in claim 28, further including:
radial expansion preventing means for preventing radial expansion of said second end of said hub.
radial expansion preventing means for preventing radial expansion of said second end of said hub.
30. A catheter assembly as set forth in claim 28, wherein the cannula and the hub are each independently formulated of either:
I. a first composition comprising:
(a) first phase which comprises a substantially non-hydrophilic polymeric component; and (b) a second phase which comprises a hydrophilic polymeric component, said first composition (i) being capable of absorbing water to an extent that it softens with a softening ratio of at least about 2:1 and/or swells with a swelling ratio of at least about 1.3:1 and (ii) when substantially completely hydrated, having an energy to break of at least about 700 N-cm/cm3 and a 2.5% Secant modulus of less than about 7,000 N/cm; or II. a second composition comprising:
a thermoplastic compound with shape-memory properties and a glass transition temperature of greater than room temperature but less that about body temperature.
I. a first composition comprising:
(a) first phase which comprises a substantially non-hydrophilic polymeric component; and (b) a second phase which comprises a hydrophilic polymeric component, said first composition (i) being capable of absorbing water to an extent that it softens with a softening ratio of at least about 2:1 and/or swells with a swelling ratio of at least about 1.3:1 and (ii) when substantially completely hydrated, having an energy to break of at least about 700 N-cm/cm3 and a 2.5% Secant modulus of less than about 7,000 N/cm; or II. a second composition comprising:
a thermoplastic compound with shape-memory properties and a glass transition temperature of greater than room temperature but less that about body temperature.
31. A catheter assembly as set forth in claim 26, wherein said cannula is of a plastic material.
32. A catheter assembly as set forth in claim 26, wherein said cannula has an unbroken wall.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US06/788,461 US4781703A (en) | 1985-10-17 | 1985-10-17 | Catheter assembly |
| US788,461 | 1985-10-17 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA1257166A true CA1257166A (en) | 1989-07-11 |
Family
ID=25144563
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA000520661A Expired CA1257166A (en) | 1985-10-17 | 1986-10-16 | Catheter assembly |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US4781703A (en) |
| EP (1) | EP0227230A1 (en) |
| JP (1) | JPS62161380A (en) |
| CA (1) | CA1257166A (en) |
Families Citing this family (96)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4874373A (en) * | 1987-03-03 | 1989-10-17 | Luther Ronald B | Dip formed catheter and assembly |
| US5195974A (en) * | 1987-10-30 | 1993-03-23 | Menlo Care, Inc. | Needle protector for a catheter assembly |
| US4846812A (en) * | 1988-03-22 | 1989-07-11 | Menlo Care, Inc. | Softening catheter |
| US4994047A (en) * | 1988-05-06 | 1991-02-19 | Menlo Care, Inc. | Multi-layer cannula structure |
| AU3936189A (en) * | 1988-08-31 | 1990-03-08 | Edward Weck Incorporated | Catheter |
| US5041100A (en) * | 1989-04-28 | 1991-08-20 | Cordis Corporation | Catheter and hydrophilic, friction-reducing coating thereon |
| US5078687A (en) * | 1989-05-17 | 1992-01-07 | Critikon, Inc. | Catheter with backflow restriction |
| NZ233609A (en) * | 1989-05-17 | 1992-10-28 | Critikon Inc | Over-the-needle catheter assembly; restriction in catheter tube to limit liquid backflow |
| CA2017951C (en) * | 1989-06-21 | 1996-02-20 | Mutlu Karakelle | Thermoplastic elastomer hydrophilic polyetherurethane expandable catheter |
| US5061254A (en) * | 1989-06-21 | 1991-10-29 | Becton, Dickinson And Company | Thermoplastic elastomeric hydrophilic polyetherurethane expandable catheter |
| IE65669B1 (en) * | 1989-06-21 | 1995-11-15 | Becton Dickinson Co | Expandable obturator and catheter assembly including same |
| US4976704A (en) * | 1989-07-17 | 1990-12-11 | Mclees Donald J | Moisture disabled needle |
| US5226899A (en) * | 1990-03-26 | 1993-07-13 | Becton, Dickinson And Company | Catheter tubing of controlled in vivo softening |
| IE902200A1 (en) * | 1990-03-26 | 1991-10-09 | Becton Dickinson Co | Thermoplastic elastomeric hydrophilic polyetherurethane¹expandable catheter |
| EP0467516A1 (en) * | 1990-07-20 | 1992-01-22 | Cabot Technology Corporation | Hemostatic stent |
| US5102401A (en) * | 1990-08-22 | 1992-04-07 | Becton, Dickinson And Company | Expandable catheter having hydrophobic surface |
| CA2068584C (en) * | 1991-06-18 | 1997-04-22 | Paul H. Burmeister | Intravascular guide wire and method for manufacture thereof |
| US5443907A (en) * | 1991-06-18 | 1995-08-22 | Scimed Life Systems, Inc. | Coating for medical insertion guides |
| US5188607A (en) * | 1991-11-12 | 1993-02-23 | Thomas Wu | Valve catheter connector assembly |
| US5290282A (en) * | 1992-06-26 | 1994-03-01 | Christopher D. Casscells | Coagulating cannula |
| US5380301A (en) * | 1992-07-10 | 1995-01-10 | Sherwood Medical Company | Catheter/hub strain relief and method of manufacture thereof |
| US5281677A (en) * | 1992-09-03 | 1994-01-25 | Becton, Dickinson And Company | Thermoplastic polyurethane blends |
| US6090072A (en) * | 1992-10-15 | 2000-07-18 | Scimed Life Systems, Inc. | Expandable introducer sheath |
| US5382260A (en) * | 1992-10-30 | 1995-01-17 | Interventional Therapeutics Corp. | Embolization device and apparatus including an introducer cartridge and method for delivering the same |
| US6051020A (en) | 1994-02-09 | 2000-04-18 | Boston Scientific Technology, Inc. | Bifurcated endoluminal prosthesis |
| US5830189A (en) * | 1995-06-07 | 1998-11-03 | Johnson & Johnson Medical, Inc. | Catheter hub to nose engagement |
| US5683378A (en) * | 1995-06-27 | 1997-11-04 | Christy; William J. | Endoscopic wound access and anchoring device method |
| US5651772A (en) * | 1996-02-28 | 1997-07-29 | Aeroquip Corporation | Needle guard assembly |
| US5817069A (en) * | 1996-02-28 | 1998-10-06 | Vadus, Inc. | Valve assembly |
| US5913848A (en) | 1996-06-06 | 1999-06-22 | Luther Medical Products, Inc. | Hard tip over-the-needle catheter and method of manufacturing the same |
| WO1998005375A1 (en) * | 1996-08-07 | 1998-02-12 | Vadus, Inc. | Needle protector |
| US5725503A (en) * | 1996-08-07 | 1998-03-10 | Aeroquip Corporation | Ratcheting needle protector assembly |
| US5800412A (en) * | 1996-10-10 | 1998-09-01 | Sts Biopolymers, Inc. | Hydrophilic coatings with hydrating agents |
| US5954698A (en) * | 1997-01-08 | 1999-09-21 | Vadus, Inc. | Catheter apparatus having valved catheter hub and needle protector |
| US6080137A (en) * | 1997-01-08 | 2000-06-27 | Vadus, Inc. | Needle protector |
| US5997517A (en) | 1997-01-27 | 1999-12-07 | Sts Biopolymers, Inc. | Bonding layers for medical device surface coatings |
| US6110483A (en) * | 1997-06-23 | 2000-08-29 | Sts Biopolymers, Inc. | Adherent, flexible hydrogel and medicated coatings |
| US6074379A (en) * | 1998-03-06 | 2000-06-13 | Sherwood Services Ag | Catheter strain relief device |
| US6179827B1 (en) * | 1998-03-16 | 2001-01-30 | Chase Medical | Catheter having integral expandable/collapsible lumen |
| US6108582A (en) * | 1998-07-02 | 2000-08-22 | Intermedics Inc. | Cardiac pacemaker lead with extendable/retractable fixation |
| US7625365B2 (en) * | 2001-09-21 | 2009-12-01 | Boston Scientific Scimed, Inc. | Intravascular device and carrier tube with interference fit member |
| EP1605866B1 (en) | 2003-03-03 | 2016-07-06 | Syntach AG | Electrical conduction block implant device |
| JP2005058464A (en) * | 2003-08-12 | 2005-03-10 | Ookiddo:Kk | Catheter |
| SE526861C2 (en) | 2003-11-17 | 2005-11-15 | Syntach Ag | Tissue lesion creation device and a set of devices for the treatment of cardiac arrhythmia disorders |
| US7314462B2 (en) | 2005-04-12 | 2008-01-01 | Span-America Medical Systems, Inc. | Passive needle-stick protector |
| AU2006264300B2 (en) | 2005-07-06 | 2012-03-08 | Vascular Pathways Inc. | Intravenous catheter insertion device and method of use |
| US20070012317A1 (en) * | 2005-07-08 | 2007-01-18 | Flagler Robert W | Medical device tube |
| US8221390B2 (en) * | 2006-04-20 | 2012-07-17 | Cook Medical Technologies Llc | Medical device delivery system having a sheath with a flared strain relief member operatively coupled by a unidirectional handle |
| US8936025B2 (en) | 2006-09-26 | 2015-01-20 | Covidien Lp | Tracheostomy tube and technique for using the same |
| WO2008103306A1 (en) * | 2007-02-21 | 2008-08-28 | Tyco Healthcare Group Lp | Expandable surgical portal |
| US9387308B2 (en) | 2007-04-23 | 2016-07-12 | Cardioguidance Biomedical, Llc | Guidewire with adjustable stiffness |
| US20080281228A1 (en) * | 2007-04-23 | 2008-11-13 | Juan Carlos Parodi | Guidewire with adjustable stiffness |
| DE602008003791D1 (en) | 2007-05-07 | 2011-01-13 | Vascular Pathways Inc | INTRODUCTION OF INTRAVENOUS CATHETER AND BLOOD DETECTING DEVICE AND METHOD OF USE |
| WO2009049677A1 (en) * | 2007-10-17 | 2009-04-23 | Syntach Ag | Shape-changing medical device, kit, method of production and method of use |
| US10232140B2 (en) * | 2007-12-18 | 2019-03-19 | Becton, Dickinson And Company | Anti-occlusion catheter adapter |
| US9402643B2 (en) | 2008-01-15 | 2016-08-02 | Novartis Ag | Targeted illumination for surgical instrument |
| US8353876B2 (en) | 2008-01-30 | 2013-01-15 | Becton, Dickinson And Company | Occlusion resistant catheters |
| WO2009097650A1 (en) * | 2008-02-07 | 2009-08-13 | Commonwealth Scientific And Industrial Research Organisation | Expandable catheter |
| DE102010005542A1 (en) * | 2010-01-23 | 2011-07-28 | Markus Dr. 79104 Cybulla | Catheter with spacer |
| US8932258B2 (en) | 2010-05-14 | 2015-01-13 | C. R. Bard, Inc. | Catheter placement device and method |
| US10384039B2 (en) | 2010-05-14 | 2019-08-20 | C. R. Bard, Inc. | Catheter insertion device including top-mounted advancement components |
| US9872971B2 (en) | 2010-05-14 | 2018-01-23 | C. R. Bard, Inc. | Guidewire extension system for a catheter placement device |
| US9950139B2 (en) | 2010-05-14 | 2018-04-24 | C. R. Bard, Inc. | Catheter placement device including guidewire and catheter control elements |
| US11925779B2 (en) | 2010-05-14 | 2024-03-12 | C. R. Bard, Inc. | Catheter insertion device including top-mounted advancement components |
| WO2012021451A1 (en) * | 2010-08-09 | 2012-02-16 | Alcon Research, Ltd. | Illuminated surgical instrument |
| US8690833B2 (en) | 2011-01-31 | 2014-04-08 | Vascular Pathways, Inc. | Intravenous catheter and insertion device with reduced blood spatter |
| EP3563898B1 (en) | 2011-02-25 | 2020-11-11 | C.R. Bard, Inc. | Medical component insertion device including a retractable needle |
| USD903101S1 (en) | 2011-05-13 | 2020-11-24 | C. R. Bard, Inc. | Catheter |
| EP3372271B1 (en) * | 2012-11-30 | 2019-12-25 | Terumo Kabushiki Kaisha | Catheter |
| US9522254B2 (en) | 2013-01-30 | 2016-12-20 | Vascular Pathways, Inc. | Systems and methods for venipuncture and catheter placement |
| US9750928B2 (en) | 2013-02-13 | 2017-09-05 | Becton, Dickinson And Company | Blood control IV catheter with stationary septum activator |
| US10376686B2 (en) | 2014-04-23 | 2019-08-13 | Becton, Dickinson And Company | Antimicrobial caps for medical connectors |
| US9789279B2 (en) | 2014-04-23 | 2017-10-17 | Becton, Dickinson And Company | Antimicrobial obturator for use with vascular access devices |
| US9675793B2 (en) | 2014-04-23 | 2017-06-13 | Becton, Dickinson And Company | Catheter tubing with extraluminal antimicrobial coating |
| US10232088B2 (en) | 2014-07-08 | 2019-03-19 | Becton, Dickinson And Company | Antimicrobial coating forming kink resistant feature on a vascular access device |
| EP2985051B1 (en) * | 2014-08-14 | 2019-12-11 | Biotronik AG | Catheter and method for producing a catheter shaft |
| WO2016037127A1 (en) | 2014-09-05 | 2016-03-10 | C.R. Bard, Inc. | Catheter insertion device including retractable needle |
| USD903100S1 (en) | 2015-05-01 | 2020-11-24 | C. R. Bard, Inc. | Catheter placement device |
| SG10202006540RA (en) | 2015-05-15 | 2020-08-28 | Bard Inc C R | Catheter placement device including an extensible needle safety component |
| US10244931B2 (en) | 2015-07-13 | 2019-04-02 | Novartis Ag | Illuminated ophthalmic infusion line and associated devices, systems, and methods |
| US10449332B2 (en) * | 2015-08-05 | 2019-10-22 | Biosense Webster (Israel) Ltd. | Guide wire luer hub |
| US10493244B2 (en) | 2015-10-28 | 2019-12-03 | Becton, Dickinson And Company | Extension tubing strain relief |
| US11173008B2 (en) | 2015-11-01 | 2021-11-16 | Alcon Inc. | Illuminated ophthalmic cannula |
| JP6751292B2 (en) * | 2015-11-26 | 2020-09-02 | テルモ株式会社 | catheter |
| US9956053B2 (en) | 2016-03-04 | 2018-05-01 | Novartis Ag | Cannula with an integrated illumination feature |
| US20170340860A1 (en) * | 2016-05-26 | 2017-11-30 | Terumo Medical Corporation | Welded on catheter hub |
| US10632290B2 (en) * | 2016-07-28 | 2020-04-28 | Tessy Plastics Corporation | Catheter assembly |
| EP3284507B1 (en) * | 2016-08-19 | 2023-12-13 | Roche Diabetes Care GmbH | Cannula unit |
| WO2018049413A1 (en) | 2016-09-12 | 2018-03-15 | C.R. Bard, Inc. | Blood control for a catheter insertion device |
| CA3054969A1 (en) | 2017-03-01 | 2018-09-07 | C.R. Bard, Inc. | Catheter insertion device |
| EP3703801B1 (en) | 2017-11-03 | 2022-10-05 | Hollister Incorporated | Methods of bonding components to polymeric substrates |
| CN111801133B (en) | 2018-03-07 | 2022-12-06 | 巴德阿克塞斯系统股份有限公司 | Guidewire advancement and blood flashback system for medical device insertion systems |
| USD921884S1 (en) | 2018-07-27 | 2021-06-08 | Bard Access Systems, Inc. | Catheter insertion device |
| EP3705153A1 (en) * | 2019-03-06 | 2020-09-09 | Roche Diabetes Care GmbH | Injection molded cannula system |
| JP7384570B2 (en) * | 2019-04-16 | 2023-11-21 | 朝日インテック株式会社 | catheter |
| CN112386778A (en) | 2019-08-19 | 2021-02-23 | 贝克顿·迪金森公司 | Midline catheter placement device |
Family Cites Families (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3030953A (en) * | 1957-10-17 | 1962-04-24 | Wilbur R Koehn | Apparatus for applying catheter |
| US3094122A (en) * | 1961-01-18 | 1963-06-18 | Theophile E Gauthier | Flexible cannula and intravenous needle combined |
| US3633579A (en) * | 1967-05-24 | 1972-01-11 | Sherwood Medical Ind Inc | Catheter placement device and method |
| US3612050A (en) * | 1969-04-01 | 1971-10-12 | David S Sheridan | Intravascular catheters |
| US3720210A (en) * | 1971-03-03 | 1973-03-13 | Baxter Laboratories Inc | Indwelling catheter device |
| US3822238A (en) * | 1972-08-02 | 1974-07-02 | Princeton Polymer Lab | Hydrophilic polyurethane polymers |
| US3975350A (en) * | 1972-08-02 | 1976-08-17 | Princeton Polymer Laboratories, Incorporated | Hydrophilic or hydrogel carrier systems such as coatings, body implants and other articles |
| US4183884A (en) * | 1973-01-24 | 1980-01-15 | Ceskoslovenska Akademie Ved | Method for manufacturing hydrogel tubes |
| US3861396A (en) * | 1973-08-08 | 1975-01-21 | Hydro Med Sciences Inc | Drainage tube |
| US4156066A (en) * | 1977-06-23 | 1979-05-22 | Tyndale Plains - Hunter Ltd. | Polyurethane polymers characterized by lactone groups and hydroxyl groups in the polymer backbone |
| US4191185A (en) * | 1977-09-06 | 1980-03-04 | Johnson & Johnson | Catheter assembly |
| DD133898A5 (en) * | 1978-01-27 | 1979-01-31 | Medline Ab | APPARATUS FOR OCCLUDING ORGANIC CHANNELS |
| US4381008A (en) * | 1978-09-08 | 1983-04-26 | Johnson & Johnson | Methods of improving surface characteristics of extruded thermoplastic tubing and products produced thereby |
| US4255550A (en) * | 1978-12-22 | 1981-03-10 | Tyndale Plains - Hunter Ltd. | Polyurethane polymers characterized by carboxylate groups and hydroxyl groups in the polymer backbone |
| SE424045B (en) * | 1979-01-12 | 1982-06-28 | Tesi Ab | CATHETER |
| FR2471195A1 (en) * | 1979-12-17 | 1981-06-19 | Technological Supply | DEVICE FOR INTRODUCING A CATHETER OR PROBE IN A BLOOD VESSEL |
| US4439558A (en) * | 1980-04-02 | 1984-03-27 | Ppg Industries, Inc. | Aqueous peroxide emulsion for use with glass fibers |
| US4439554A (en) * | 1980-07-07 | 1984-03-27 | American Dental Association Health Foundation | Dioxo-piperidine substituted tertiary aromatic amine accelerators in acrylic resin |
| US4439583A (en) * | 1980-11-12 | 1984-03-27 | Tyndale Plains-Hunter, Ltd. | Polyurethane diacrylate compositions useful in forming canulae |
| US4408023A (en) * | 1980-11-12 | 1983-10-04 | Tyndale Plains-Hunter, Ltd. | Polyurethane diacrylate compositions useful for contact lenses and the like |
| US4424305A (en) * | 1980-11-12 | 1984-01-03 | Tyndale Plains-Hunter, Ltd. | Surgical implants formed of polyurethane diacrylate compositions |
| US4439584A (en) * | 1980-11-12 | 1984-03-27 | Tyndale Plains-Hunter, Ltd. | Gas and ion permeable membranes formed of polyurethane diacrylate compositions |
| US4411655A (en) * | 1981-11-30 | 1983-10-25 | Schreck David M | Apparatus and method for percutaneous catheterization |
| US4511163A (en) * | 1982-07-14 | 1985-04-16 | Mead Johnson & Company | Adaptable tip tubing connector |
| US4480642A (en) * | 1982-07-26 | 1984-11-06 | Health Products Research, Inc. | Dilation device for the cervix |
| US4449693A (en) * | 1982-09-30 | 1984-05-22 | Gereg Gordon A | Catheter check valve |
| US4526579A (en) * | 1983-06-17 | 1985-07-02 | Pfizer Inc. | Method for graft copolymerization to natural rubber articles |
| EP0142222A1 (en) * | 1983-08-19 | 1985-05-22 | Warner-Lambert Company | Infusion hub and tubing assembly |
| US4610671A (en) * | 1985-03-28 | 1986-09-09 | Luther Medical Products, Inc. | Assembly of stylet and catheter |
-
1985
- 1985-10-17 US US06/788,461 patent/US4781703A/en not_active Expired - Lifetime
-
1986
- 1986-10-13 EP EP86307898A patent/EP0227230A1/en not_active Ceased
- 1986-10-16 CA CA000520661A patent/CA1257166A/en not_active Expired
- 1986-10-17 JP JP61245620A patent/JPS62161380A/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| JPS62161380A (en) | 1987-07-17 |
| US4781703A (en) | 1988-11-01 |
| EP0227230A1 (en) | 1987-07-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA1257166A (en) | Catheter assembly | |
| US4840622A (en) | Kink resistant catheter | |
| US4846812A (en) | Softening catheter | |
| US4955863A (en) | Adjustable catheter assembly | |
| US5156596A (en) | Catheter with changeable number of lumens | |
| EP0233055B1 (en) | Adjustable catheter assembly | |
| US20240017038A1 (en) | Catheter having an expandable lumen and method of manufacture | |
| CA1314454C (en) | Multi-layer cannula structure | |
| US20210162172A1 (en) | Urinary catheter having a soft tip | |
| US4883699A (en) | Polymeric article having high tensile energy to break when hydrated | |
| US4874373A (en) | Dip formed catheter and assembly | |
| EP3263167B1 (en) | Urinary catheter with varying properties | |
| US4402685A (en) | Dividable catheter | |
| AU707219B2 (en) | Connecting arrangement and process for connecting two separate parts of a medical system | |
| CA2204808A1 (en) | A fuseless soft tip catheter and method for making the same | |
| EP0195813B1 (en) | Multiple phase polymeric compositions | |
| JPH11192300A (en) | Indwelling catheter | |
| CA1273730A (en) | Hydrogel blends |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MKEX | Expiry |